ES8606357A1 - Procedimiento para la obtencion de oxazolidinonas trisustituidas - Google Patents

Procedimiento para la obtencion de oxazolidinonas trisustituidas

Info

Publication number
ES8606357A1
ES8606357A1 ES533017A ES533017A ES8606357A1 ES 8606357 A1 ES8606357 A1 ES 8606357A1 ES 533017 A ES533017 A ES 533017A ES 533017 A ES533017 A ES 533017A ES 8606357 A1 ES8606357 A1 ES 8606357A1
Authority
ES
Spain
Prior art keywords
hydrogen
alk
formula
image
lower alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES533017A
Other languages
English (en)
Other versions
ES533017A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of ES8606357A1 publication Critical patent/ES8606357A1/es
Publication of ES533017A0 publication Critical patent/ES533017A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20—Spiro-condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/36—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring increasing the number of carbon atoms by reactions with formation of hydroxy groups, which may occur via intermediates being derivatives of hydroxy, e.g. O-metal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • C07C33/48—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
    • C07C33/483—Monocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/04—Saturated ethers
    • C07C43/13—Saturated ethers containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/50—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
    • C07D211/98—Nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE OXAZOLIDIONONAS TRISUSTITUIDAS. COMPRENDE: A) HACER REACCIONAR UN COMPUESTO DE FORMULA (V) CON UN DERIVADO FUNCIONAL DEL ACIDO CARBONICO DE FORMULA (VI), EN TOLUENO, ENTRE 10 Y 35JC, PARA OBTENER UN COMPUESTO DE FORMULA (III); B) CICLIZAR INTERMOLECULARMENTE EL COMPUESTO DE FORMULA (III), EN PRESENCIA DE AGENTES DE CONDENSACION BASICOS, COMO ALCOHOLATOS, HIDROXIDOS O CARBONATOS DE METALES ALCALINOS O ALCALINO-TERREOS, EN UN DISOLVENTE INERTE, Y BAJO CALENTAMIENTO O ENFRIAMIENTO, PARA OBTENER OXAZOLIDINONAS TRISUSTITUIDAS, DE FORMULA (I). SIENDO: ALK, ALQUILENO INFERIOR; R1, RESTO ARILO O HETEROARILO; R2 Y R3, INDEPENDIENTEMENTE H, O ALQUILO INFERIOR; X1, GRUPO DE SALIDA NUCLEOFUGO; X2 Y X3, ORO; E Y1, NIDROXIETERADO O ESTERIFICADO CAPAZ DE REACCION. SE UTILIZAN COMO ANTIDEPRESIVOS Y ESTIMULANTES NO SIMILARES A LA ANFETAMINA.
ES533017A 1983-06-02 1984-05-31 Procedimiento para la obtencion de oxazolidinonas trisustituidas Expired ES8606357A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH301383 1983-06-02

Publications (2)

Publication Number Publication Date
ES8606357A1 true ES8606357A1 (es) 1986-04-01
ES533017A0 ES533017A0 (es) 1986-04-01

Family

ID=4246669

Family Applications (2)

Application Number Title Priority Date Filing Date
ES533017A Expired ES8606357A1 (es) 1983-06-02 1984-05-31 Procedimiento para la obtencion de oxazolidinonas trisustituidas
ES546519A Expired ES8702381A1 (es) 1983-06-02 1985-08-29 Procedimiento para la obtencion de oxazolidinonas trisusti- tuidas

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES546519A Expired ES8702381A1 (es) 1983-06-02 1985-08-29 Procedimiento para la obtencion de oxazolidinonas trisusti- tuidas

Country Status (13)

Country Link
EP (1) EP0128120A3 (es)
JP (1) JPS606658A (es)
KR (1) KR850000444A (es)
AU (1) AU2897984A (es)
DD (1) DD223616A5 (es)
DK (1) DK272984A (es)
ES (2) ES8606357A1 (es)
FI (1) FI842159A (es)
GR (1) GR82056B (es)
HU (1) HUT34981A (es)
IL (1) IL71964A0 (es)
PT (1) PT78677A (es)
ZA (1) ZA844061B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2624861B1 (fr) * 1987-12-21 1990-06-01 Delalande Sa Carbamates tricycliques, leur procede de preparation et leur application en therapeutique
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714740D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1445729A1 (de) * 1963-04-06 1969-10-02 Bayer Ag Verfahren zur Herstellung von Hexahydro-1-aryl-3-imino-3H-oxazolo-[3,4-a]pyridinen
US3496185A (en) * 1968-02-14 1970-02-17 Smithkline Corp Oxazolo- and thiazolo(3,4-a)-pyridine derivatives

Also Published As

Publication number Publication date
ES8702381A1 (es) 1986-12-16
ZA844061B (en) 1985-01-30
KR850000444A (ko) 1985-02-27
GR82056B (es) 1984-12-13
DK272984D0 (da) 1984-06-01
JPS606658A (ja) 1985-01-14
DK272984A (da) 1984-12-03
DD223616A5 (de) 1985-06-19
AU2897984A (en) 1984-12-06
EP0128120A2 (de) 1984-12-12
ES546519A0 (es) 1986-12-16
IL71964A0 (en) 1984-09-30
HUT34981A (en) 1985-05-28
FI842159A0 (fi) 1984-05-30
EP0128120A3 (de) 1985-11-13
PT78677A (en) 1984-07-01
ES533017A0 (es) 1986-04-01
FI842159A (fi) 1984-12-03

Similar Documents

Publication Publication Date Title
CA2095444A1 (en) Fused pyrazine derivatives
IL98681A (en) Pharmaceutical compositions comprising hydroxamate derivatives for iron removal from mammalian cells and from pathogenic organisms and some novel hydroxamate derivatives
ES429221A1 (es) Procedimiento para la preparacion de nuevas amidas de aci- dos n-(1-omega-fenilalcohil)-piperidil-4) - n-(alfa-piridil)-carboxilicos.
GB1450010A (en) Preparation of triamino pyrimidine n-oxides
ES8606357A1 (es) Procedimiento para la obtencion de oxazolidinonas trisustituidas
ES417638A1 (es) Procedimiento para preparar oxazoles 2,4,5-trisustituidos.
ES475588A1 (es) Procedimiento para la obtencion de derivados del acido inde-no -2,1-b- tiofen-2-oxamico
ES8203358A1 (es) Metodo de producir lactamas antihipertensoras
ES448389A1 (es) Procedimiento para la preparacion de isotiazolilureas susti-tuidas.
ES8204992A1 (es) Procedimiento para la obtencion de compuestos poliazahetero-ciclicos
ES392848A1 (es) Un procedimiento para la preparacion de nuevos derivados de indenopirrol.
GB1421279A (en) 3-heterocyclicthiomethylcephalosporins
ES373909A1 (es) Procedimiento para la preparacion de quinazolinas.
ES2082971T3 (es) Esteres de fosfato de acilo y modificacion de proteinas con los mismos.
ES422827A1 (es) Procedimiento para la produccion de benzoilfenilguanidinas.
ES8202030A1 (es) Procedimiento para la preparacion de derivados de rifamicina
KR860004040A (ko) 3,4-디아졸 유도체의 제조방법
ES468532A1 (es) Un procedimiento para preparar un compuesto de sulfonio re- gulador del crecimiento de las plantas
ATE65998T1 (de) Dihydropyran-derivate.
ES394416A1 (es) Procedimiento para la obtencion de colorantes cationicos.
FR2312255B1 (es)
GB1327042A (en) Oxazole derivatives their preparation and pharmaceutical compositions containing the same
GB1429512A (en) Polymeric compositions
CA2175943A1 (en) Squeak and deletion resistant imaging member and system
ES8103749A1 (es) Procedimiento para la preparacion de 5,6,7,8-tetrahidropira-zolo (3,4-b)(1,5)diazepin-1h,4h-5,7-dionas